- 耐容量、(放射線)耐線量
WordNet
- travel or traverse (a distance); "This car does 150 miles per hour"; "We did 6 miles on our hike every day"
- the syllable naming the first (tonic) note of any major scale in solmization (同)doh, ut
- proceed or get along; "How is she doing in her new job?"; "How are you making out in graduate school?"; "Hes come a long way" (同)fare, make_out, come, get along
- create or design, often in a certain way; "Do my room in blue"; "I did this piece in wood to express my love for the forest" (同)make
- carry on or function; "We could do with a little more help around here" (同)manage
- get (something) done; "I did my job" (同)perform
- treat with an agent; add (an agent) to; "The ray dosed the paint"
- the quantity of an active agent (substance or radiation) taken in or absorbed at any one time (同)dosage
- a measured portion of medicine taken at any one time (同)dosage
- capable of being borne or endured; "the climate is at least tolerable"
- treated with some kind of application; "a mustache dosed with bear grease"
PrepTutorEJDIC
- 《疑問文・否定文を作る》 / 《否定命令文を作る》 / 《助動詞とbe動詞のどちらも含まない文に用いて付加疑問を作る》 / 《強意語として》 / 《文》《助動詞とbe動詞のどちらも含まない文に用いて倒置文を作る》 / 《あいづちを打つ場合に》 / 《先行する動詞またはそれを含む述部の代用》 / 《so,nor,neitherで始まる簡略文で》 / …‘を'『する』,行う,果たす / 《通例have done,時にbe doneの形で》…‘を'『終える』,済ませる / …‘を'作る,作り出す / …‘を'『処理する』,整える,片付ける / 〈学課〉‘を'『勉強する』,専攻する / 〈利益・害など〉‘を'与える,もたらす / 〈人〉‘に'『役立つ』,用が足りる(serve) / …の速度で進む,距離を行く / …‘を'見物する / 〈劇〉‘を'上演する;…‘の'役を演じる / …の役目(仕事)をする / 《おもに英》…‘を'だます,かつぐ / 《話》…をへとへとにさせる / 『する』;活動する / 《通例have done,時にbe doneの形で》(…を)『終える』,済ます《+『with』+『名』》 / 〈事が〉『運ぶ』;〈人が〉暮らしていく,健康である / 〈物が〉(…に)『間に合う』,十分である;〈人が〉(…に)役に立つ,向く《+『for』+『名』》 / 《複数形で》すべきこと / 〈C〉《おもに英》大宴会,大パーティー / 〈C〉《英話》詐欺,ぺてん
- ド(全音階の第1音)
- (おもに飲み薬1回分の)『服用量』 / (痛いこと・いやなことの)1回分,一定量 / (人などが受ける放射線の)線量 / 性病 / (…を)…‘に'投薬する,服用させる《+『名』+『with』+『名』》
- がまんできる,耐えられる / 相当の;まあまあの
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/05/07 21:47:09」(JST)
wiki en
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 肝疾患を有する患者における化学療法による肝毒性および用量調整 chemotherapy hepatotoxicity and dose modification in patients with liver disease
- 2. 分化型甲状腺癌：放射性ヨード治療 differentiated thyroid cancer radioiodine treatment
- 3. 限局期びまん性大細胞B細胞性リンパ腫の初期治療 initial treatment of limited stage diffuse large b cell lymphoma
- 4. 強直性脊椎炎、末梢関節炎を主体とする脊椎関節炎、およびX線所見が認められない軸性脊椎関節炎における抗腫瘍壊死因子α（TNF-α）剤使用のための一般的ガイドライン general guidelines for use of anti tumor necrosis factor alpha agents in ankylosing spondylitis and in peripheral and non radiographic axial spondyloarthritis
- 5. 全般性不安障害に対する薬物療法 pharmacotherapy for generalized anxiety disorder
English Journal
- A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT).
- Ding X1, Dionisi F1, Tang S1, Ingram M1, Hung CY1, Prionas E1, Lichtenwalner P1, Butterwick I1, Zhai H1, Yin L1, Lin H1, Kassaee A1, Avery S2.
- Medical dosimetry : official journal of the American Association of Medical Dosimetrists.Med Dosim.2014 Summer;39(2):139-45. doi: 10.1016/j.meddos.2013.11.005. Epub 2014 Mar 21.
- With traditional photon therapy to treat large postoperative pancreatic target volume, it often leads to poor tolerance of the therapy delivered and may contribute to interrupted treatment course. This study was performed to evaluate the potential advantage of using passive-scattering (PS) and modul
- PMID 24661778
- Cumulative risk assessment for plasticizer-contaminated food using the hazard index approach.
- Chang JW1, Yan BR2, Chang MH3, Tseng SH3, Kao YM3, Chen JC4, Lee CC5.
- Environmental pollution (Barking, Essex : 1987).Environ Pollut.2014 Jun;189:77-84. doi: 10.1016/j.envpol.2014.02.005. Epub 2014 Mar 15.
- Phthalates strongly and adversely affect reproduction, development and liver function. We did a cumulative risk assessment for simultaneous exposure to nine phthalates using the hazard index (HI) and the levels of nine phthalates in 1200 foodstuff samples. DEHP (di-2-ethylhexyl phthalate) present th
- PMID 24631976
- Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.
- Chien AJ1, Munster PN, Melisko ME, Rugo HS, Park JW, Goga A, Auerback G, Khanafshar E, Ordovas K, Koch KM, Moasser MM.
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology.J Clin Oncol.2014 May 10;32(14):1472-9. doi: 10.1200/JCO.2013.52.1161. Epub 2014 Apr 7.
- PURPOSE: The highly effective treatment of human epidermal growth factor receptor (HER) 2-amplified breast cancer has proven challenging because of a signal buffering capacity inherent in the functionally relevant HER2-HER3 target. HER2-HER3 signaling can be inactivated by doses of lapatinib that fu
- PMID 24711549
Japanese Journal
- A Feasibility Study Assessing Tolerability of Daily versus Twice Weekly Trimethoprim-Sulfamethoxazole Regimen for Prophylaxis against Pneumocystis Pneumonia in Patients with Systemic Autoimmune Diseases on Glucocorticoid Therapy
- YAMAMOTO Tatsuhiro,HASUNUMA Tomoko,TAKAGI Kenji,AKIMOTO Kimiko,SHIKANO Kotaro,KABURAKI Makoto,MURAOKA Sei,KITAHARA Kanako,TANAKA Nahoko,KANEKO Kaichi,KUSUNOKI Yoshie,ENDO Hirahito,KAWAI Shinichi
- 臨床薬理 45(3), 89-92, 2014
- … Objective: To determine the feasibility of low-dose, intermittent administration of trimethoprim-sulfamethoxazole (TMP/SMX) for prophylaxis against pneumocystis pneumonia (PCP) in patients with systemic autoimmune diseases receiving medium- to high-dose glucocorticoid therapy.Methods: A randomized prospective study was performed. …
- NAID 130004679387
- リツキシマブ併用ソブゾキサンおよびエトポシドの経口少量療法が奏効した高齢者ヒトヘルペスウイルス8陰性Primary effusion lymphoma-like lymphoma
- 豊田 康祐,安部 康信,津田 麻理子,土師 正二郎,崔 日承,末廣 陽子,喜安 純一,大島 孝一,鵜池 直邦
- 臨床血液 55(7), 815-819, 2014
- Primary effusion lymphoma (PEL)は体腔液中に限局して腫瘍細胞が増殖する稀なB細胞性リンパ腫であり，原則的に明らかな腫瘤形成は認められないとされ，human herpes virus 8 (HHV8)感染が陽性である。しかしながら本邦を中心にHHV8感染が認められないPEL類似の症例も報告されており，これらをPEL-like lymphoma (PEL-LL)とする疾患 …
- NAID 130004678960
- A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: Safety report of the UFT/LV study
- Saiura Akio,Yamamoto Junji,Hasegawa Kiyoshi,Oba Masaru,Takayama Tadatoshi,Miyagawa Shinichi,Ijichi Masayoshi,Teruya Masanori,Yoshimi Fuyo,Kawasaki Seiji,Koyama Hiroto,Makuuchi Masatoshi,Kokudo Norihiro
- Drug Discoveries & Therapeutics 8(1), 48-56, 2014
- … In the UFT/LV group, the completion rate of UFT/LV was 54.9%, the relative dose intensity was 70.8% and grade 3 or higher adverse events occurred in 12.2% of the patients. … Most other adverse events were grade 2 or lower and tolerable. …
- NAID 130003397399
Related Links
- maximum tolerable dose The highest dose of a substance that can be given without causing serious weight loss or other signs of toxicity. maximum tolerable dose The highest dose of a substance that can be given without causing ...
- 1. Int J Clin Oncol. 2014 Dec;19(6):1029-36. doi: 10.1007/s10147-014-0668-4. Epub 2014 Feb 13. Is intra-patient sorafenib dose re-escalation safe and tolerable in patients with advanced hepatocellular carcinoma? Ogasawara S(1 ...
Related Pictures
★リンクテーブル★
| リンク元 | 「耐容量」「耐線量」 |
| 関連記事 | 「do」「dose」「tolerable」「dosing」 |
「耐容量」
- 英
- tolerable dose
- 関
- 耐線量
「耐線量」
- 英
- tolerable dose
- 関
- 耐容量
「do」
- v.
- する、行う
「dose」
- n.
「tolerable」
redirect 容認できる
「dosing」
- n.